EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Tocilizumab as a novel bridging therapy for surgery in dedifferentiated liposarcoma complicated by paraneoplastic leukemoid reaction, severe anemia, and thrombocytopenia: a case report

Jinjin Li, Ke Li, Shanshan Yu, Ya Li, Jiang Min, Zhen Huang, Zhengqiang Wei

Frontiers in Oncology · 05.05.2026 · 16

DOI: 10.3389/fonc.2026.1762067 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Frontiers in Oncology, online erschienen am 05.05.2026. Verfasst von Jinjin Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Dedifferentiated liposarcoma (DDLPS) is a malignant mesenchymal tumor. While paraneoplastic leukemoid reaction (PLR) has been sporadically reported in DDLPS, its coexistence with severe anemia and thrombocytopenia, constituting a severe cytokine release syndrome (CRS), is exceedingly rare and presents a significant diagnostic and therapeutic challenge. Case presentation A 56-year-old male with recurrent retroperitoneal well-differentiated liposarcoma presented with high fever, profound leukocytosis (WBC up to 43×10 9 /L), severe anemia (Hb 30 g/L), and thrombocytopenia (platelets 10×10 9 /L), which precluded immediate surgery. Extensive workup ruled out infection and hematological malignancies. The clinical picture was consistent with a tumor-induced CRS, evidenced by markedly elevated interleukin-6 (IL-6) and C-reactive protein (CRP). Following a multidisciplinary discussion, the patient received intravenous tocilizumab (an IL-6 receptor antagonist) and methylprednisolone. His fever resolved rapidly, and hematological parameters improved significantly, facilitating successful tumor resection. Postoperative pathology confirmed DDLPS. All paraneoplastic symptoms and laboratory abnormalities normalized after surgery. However, at the second follow-up, tumor recurrence was observed along with a marked elevation of the WBC, which again decreased following the subsequent surgical resection.

Conclusion

This case highlights that DDLPS can trigger CRS, which manifests with clinical features mimicking severe infection and leading to critical cytopenias that complicate surgical management. IL-6 pathway blockade with agents such as tocilizumab may be an effective bridging therapy to stabilize the systemic inflammatory state and create a safe window for surgical intervention.

Schlagwörter

Stichwörter der Autor:innen

anemiacytokine release syndromededifferentiated liposarcomaleukocytosisparaneoplastic syndromethrombocytopeniatocilizumab

Autor:innen und Institutionen

  • Department of Gastrointestinal Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • Department of General Surgery, Chongqing Traditional Chinese Medicine Hospital, Chongqing, China.
  • Department of Pathology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Zitieren

APA

Li, J., Li, K., Yu, S., Li, Y., Min, J., Huang, Z., & Wei, Z. (2026). Tocilizumab as a novel bridging therapy for surgery in dedifferentiated liposarcoma complicated by paraneoplastic leukemoid reaction, severe anemia, and thrombocytopenia: a case report. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1762067

Vancouver

Li J, Li K, Yu S, Li Y, Min J, Huang Z, et al. Tocilizumab as a novel bridging therapy for surgery in dedifferentiated liposarcoma complicated by paraneoplastic leukemoid reaction, severe anemia, and thrombocytopenia: a case report. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1762067

BibTeX
@article{Li2026,
  author = {Li, Jinjin and Li, Ke and Yu, Shanshan and Li, Ya and Min, Jiang and Huang, Zhen and Wei, Zhengqiang},
  title = {Tocilizumab as a novel bridging therapy for surgery in dedifferentiated liposarcoma complicated by paraneoplastic leukemoid reaction, severe anemia, and thrombocytopenia: a case report},
  journal = {Frontiers in Oncology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fonc.2026.1762067}
}
Kostenlos starten →